WisdomTree BioRevolution Fund Rating $13.01 -0.46 (-3.43%) Closing price 04/25/2025 03:41 PM EasternExtended Trading$13.01 0.00 (-0.01%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.75Holdings in WDNA have an aggregate rating of Moderate Buy based on 689 analyst ratings issued in the past year covering 44 companies (68.4% of the portfolio).WDNA Aggregate Price Target$13.01High Prediction$13.01Average Prediction$13.01Low Prediction$13.01Holdings in WDNA have an aggregate price target of $13.01 and a range of $13.01 to $13.01 covering 44 companies (68.4% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.38%NTRANatera$153.79-0.4%2.8666 of 5 stars3.00$175.76 14.3%16Insider TradeNews CoveragePositive News3.44%TWSTTwist Bioscience$40.11-0.1%3.6934 of 5 stars2.70$52.80 31.6%10News CoveragePositive News2.91%LLYEli Lilly and Company$884.94+2.9%4.9185 of 5 stars2.89$1,017.00 14.9%19Upcoming EarningsAnalyst Revision2.85%BBIOBridgeBio Pharma$36.31+1.0%4.534 of 5 stars2.92$53.00 46.0%12Upcoming EarningsInsider TradeGap Down2.79%BPMCBlueprint Medicines$87.66+1.8%2.5536 of 5 stars2.68$124.68 42.2%22Upcoming EarningsNews CoveragePositive News2.39%VCELVericel$39.73-3.3%2.2752 of 5 stars3.00$60.86 53.2%7Positive News2.25%VCYTVeracyte$32.23+0.3%3.9418 of 5 stars2.70$42.60 32.2%10Short Interest ↑Analyst RevisionNews Coverage2.04%VRTXVertex Pharmaceuticals$493.84+0.3%3.9254 of 5 stars2.64$514.91 4.3%25Upcoming EarningsAnalyst RevisionPositive News1.90%GILDGilead Sciences$103.17-2.8%4.5801 of 5 stars2.78$109.43 6.1%27Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionGap Down1.84%AGIOAgios Pharmaceuticals$29.45+0.6%4.0993 of 5 stars2.56$56.57 92.1%9Upcoming Earnings1.74%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.6553 of 5 stars2.77$315.58 25.5%26Upcoming EarningsAnalyst UpgradePositive News1.73%UTHRUnited Therapeutics$291.38-1.7%4.8943 of 5 stars2.67$390.17 33.9%12Upcoming EarningsAnalyst ForecastInsider TradeAnalyst RevisionNews CoveragePositive NewsGap Down1.61%AMGNAmgen$280.84+0.4%4.4319 of 5 stars2.43$310.57 10.6%23Upcoming EarningsPositive News1.59%TSNTyson Foods$60.58-1.4%4.451 of 5 stars2.10$61.78 2.0%10News CoveragePositive News1.53%CTVACorteva$61.50-0.3%4.4737 of 5 stars2.72$68.13 10.8%18Upcoming EarningsPositive News1.49%JNJJohnson & Johnson$154.54-0.3%4.6852 of 5 stars2.56$171.82 11.2%18Positive News1.46%LHLaboratory Co. of America$228.60+0.0%4.7121 of 5 stars2.87$268.77 17.6%15Upcoming EarningsShort Interest ↑News Coverage1.37%BMYBristol-Myers Squibb$47.86-1.7%4.5617 of 5 stars2.33$58.00 21.2%21Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews Coverage1.36%RAREUltragenyx Pharmaceutical$38.09+1.2%4.2291 of 5 stars2.93$92.79 143.6%14Upcoming EarningsShort Interest ↑News Coverage1.35%AZNAstraZeneca$69.57+0.0%3.756 of 5 stars3.10$88.00 26.5%10Upcoming EarningsShort Interest ↓Analyst RevisionNews CoveragePositive News1.35%DHRDanaher$197.37+0.4%4.895 of 5 stars2.80$264.40 34.0%20Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoveragePositive News1.34%QGENQiagen$42.10-2.2%3.6411 of 5 stars2.27$47.83 13.6%11Analyst Revision1.30%ZTSZoetis$153.58+0.8%4.495 of 5 stars3.08$214.40 39.6%12Positive News1.28%DDDuPont de Nemours$65.70-0.5%4.8695 of 5 stars2.79$86.93 32.3%14Upcoming EarningsAnalyst Forecast1.27%BNTXBioNTech$102.02-15.4%2.3681 of 5 stars2.89$143.44 40.6%18Analyst RevisionNews CoveragePositive NewsHigh Trading Volume1.27%SDGRSchrödinger$26.45+1.2%1.6825 of 5 stars3.00$33.00 24.8%8Upcoming EarningsPositive News1.21%RGENRepligen$144.75-0.3%4.666 of 5 stars2.57$176.82 22.2%14Upcoming Earnings1.17%DARDarling Ingredients$31.98+5.0%4.1215 of 5 stars2.89$50.33 57.4%9Earnings ReportAnalyst ForecastNews CoveragePositive News1.17%CRSPCRISPR Therapeutics$38.27-2.1%2.7645 of 5 stars2.48$73.11 91.0%211.16%TMOThermo Fisher Scientific$424.02-0.6%4.8461 of 5 stars2.81$616.95 45.5%21Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.12%FOLDAmicus Therapeutics$7.35+2.1%4.3447 of 5 stars2.78$16.75 127.9%9Upcoming EarningsPositive News1.09%IONSIonis Pharmaceuticals$29.70+0.4%4.1496 of 5 stars2.70$56.72 91.0%20Upcoming EarningsPositive News1.07%REGNRegeneron Pharmaceuticals$602.64+0.5%4.822 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.06%GMABGenmab A/S$20.59+0.2%4.444 of 5 stars2.69$39.17 90.2%13Analyst Revision1.05%MRKMerck & Co., Inc.$82.83+3.7%5 of 5 stars2.59$111.13 34.2%22Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionPositive NewsHigh Trading Volume1.03%ARGXargenx$614.76+2.4%3.0298 of 5 stars2.91$699.28 13.7%23News CoveragePositive News0.98%NEONeoGenomics$10.27+1.8%2.6893 of 5 stars2.80$19.30 87.9%10Upcoming EarningsPositive News0.97%BEAMBeam Therapeutics$19.52-3.2%3.016 of 5 stars3.00$49.45 153.4%14Options Volume0.95%STOKStoke Therapeutics$9.76-1.2%3.3593 of 5 stars3.13$24.67 152.7%8Positive News0.95%EXASExact Sciences$45.46-0.3%4.3837 of 5 stars2.95$69.25 52.3%22Upcoming EarningsAnalyst RevisionNews Coverage0.94%GERNGeron$1.423.8723 of 5 stars2.82$5.75 304.9%11Analyst RevisionGap Down0.93%ADMArcher-Daniels-Midland$48.24-1.1%4.4666 of 5 stars1.88$52.75 9.3%80.86%TECHBio-Techne$50.24-1.1%4.8135 of 5 stars2.38$81.14 61.5%8Upcoming Earnings0.85%BMRNBioMarin Pharmaceutical$63.30+0.9%4.9163 of 5 stars2.70$93.14 47.1%23Upcoming EarningsAnalyst UpgradeNews CoveragePositive News This page (BATS:WDNA) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
